Special Report: The Lab Kickback Risks of “Freebies”
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Labs will have to submit Z-Codes with every molecular pathology testing code billed to UnitedHealthcare, starting Aug. 1.
Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.
Individualized quality control plans offer flexibility and the capacity to seamlessly adopt new nonwaived tests, practices, and technologies.
Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
While ChatGPT has its place, allowing lab staff to use it exposes you to liabilities—here are some ways to manage the risks involved.
As generative AI chatbot use increases, labs may want to implement a written acceptable use policy for staff.
A written policy helps establish your right to do excluded persons checks and take appropriate actions if they come back positive.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.